Jinping Liu

Title: Innovations of Jinping Liu in Anti-Colitis Drug Development

Introduction

Jinping Liu is a notable inventor based in Changchun, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for inflammatory bowel disease. His innovative work has led to the creation of a promising anti-colitis drug.

Latest Patents

Jinping Liu holds a patent for the "Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug." This patent highlights the significant anti-ulcerative-colitis activity of oleanolic acid-28-O-β-D-glucopyranoside compared to its parent compound and other analogues. The compound demonstrates equivalent efficacy to Mesalazine, a first-line treatment for inflammatory bowel disease, while potentially avoiding the salicylic acid anaphylaxis associated with Mesalazine. This innovation presents a promising application prospect in the pharmaceutical industry.

Career Highlights

Jinping Liu is affiliated with Jilin University, where he continues to engage in research and development. His work has garnered attention for its potential impact on treating inflammatory bowel diseases, showcasing his dedication to advancing medical science.

Collaborations

Jinping Liu collaborates with esteemed colleagues, including Hongqiang Lin and Caixia Wang. Their combined expertise contributes to the innovative research and development efforts at Jilin University.

Conclusion

Jinping Liu's contributions to the field of anti-colitis drug development exemplify the importance of innovation in addressing medical challenges. His work not only advances pharmaceutical science but also holds the potential to improve patient outcomes in the treatment of inflammatory bowel disease.